2.90
Seastar Medical Holding Corp stock is traded at $2.90, with a volume of 140.46K.
It is down -5.23% in the last 24 hours and down -5.84% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$3.06
Open:
$3.1
24h Volume:
140.46K
Relative Volume:
0.38
Market Cap:
$15.26M
Revenue:
$1.44M
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.6063
EPS:
-4.783
Net Cash Flow:
$-13.71M
1W Performance:
-19.67%
1M Performance:
-5.84%
6M Performance:
-30.29%
1Y Performance:
-53.98%
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ICU
Seastar Medical Holding Corp
|
2.90 | 15.26M | 1.44M | -11.90M | -13.71M | -4.783 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Seastar Medical Holding Corp Stock (ICU) Latest News
SeaStar Medical Holding Corporation announced that it has received $3.301572 million in funding - www.marketscreener.com
Warrants for up to 59,780 shares accompany SeaStar Medical (ICU)'s capital raise. - Stock Titan
SeaStar Medical announces exercise of warrants - Medical Buyer
SeaStar Medical raises $3.3M through warrant exercise By Investing.com - Investing.com South Africa
SeaStar Medical raises $3.3M through warrant exercise - Investing.com
SeaStar Medical raises $3.3M via warrant exercise offering - Dealroom
SeaStar Medical raises $3.3M through warrant exercise By Investing.com - Investing.com Canada
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds - The Manila Times
SeaStar Medical raises $3.3M through warrant exercise at reduced price - StreetInsider
SeaStar Medical’s deal would give investors rights to buy up to 1.71 million shares. - Stock Titan
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds - GlobeNewswire
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds - GlobeNewswire
SeaStar Medical’s Dr. Humes Named University of Michigan Distinguished University Innovator of the Year for SCD Therapy - Quiver Quantitative
Avalo Therapeutics, Inc. (AVTX) Stock Price, News, Quote & History - Yahoo Finance
SeaStar Medical at H.C. Wainwright: adult trial looms over small cap By Investing.com - Investing.com South Africa
SeaStar Medical at H.C. Wainwright: adult trial looms over small cap - Investing.com
SeaStar Medical at H.C. Wainwright: adult trial looms over small cap - Investing.com Canada
SeaStar Medical at H.C. Wainwright: adult trial looms over small cap - Investing.com UK
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference - Yahoo Finance
SeaStar Medical Holding (NasdaqCM:ICU) Stock Forecast & Analyst Predictions - Simply Wall Street
ICU: Continued Revenue Growth for QUELIMMUNE - Smartkarma
ICU: Continued Revenue Growth for QUELIMMUNE® - Yahoo Finance
ICU Q2 2026 Earnings: Loss of -$0.91 Beats Estimates by 7.11% Despite No Reported RevenueRevenue Report - careplusvn.com
SeaStar Medical (ICU) Q2 2026 Earnings: Loss Narrows More Than Expected, No Revenue Still ReportedPost-Announcement Reaction - vinanet.vn
SeaStar Medical Holding earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
SeaStar Medical secures ICD-10-PCS codes for SCD therapy - scanx.trade
SeaStar Medical Q2 Results: Revenue up 82% YoY to $0.6 million - scanx.trade
SeaStar Medical Holding earnings missed by $0.04, revenue fell short of estimates - Investing.com
SeaStar Medical Holding earnings missed by $0.04, revenue fell short of estimates - Investing.com UK
Earnings call transcript: SeaStar Medical misses Q2 2026 forecasts as stock falls - Investing.com
SeaStar Medical Holding Corp reports results for the quarter ended June 30Earnings Summary - TradingView
SeaStar Medical (ICU) grows QUELIMMUNE sales but warns on going concern - stocktitan.net
SeaStar Medical Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SEASTAR MEDICAL HOLDING ($ICU) Releases Q2 2026 Earnings - Quiver Quantitative
SeaStar Medical Adds 3 Customers From Children's Hospitals for Its Therapy - Stock Titan
SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswire
SeaStar Medical Q2 Revenue Climbs 82 Percent to $615000 - Quiver Quantitative
SeaStar Medical Q2 Revenue Climbs 82 Percent to $615000 | ICUCW Stock News - Quiver Quantitative
SEASTAR MEDICAL HOLDING ($ICU) Releases Q2 2026 Earnings - Quiver Quantitative
SeaStar Medical Holding Corp (ICU) Q2 2026 Earnings Report Previ - GuruFocus
SeaStar Medical Holding Corp expected to post a loss of 97 cents a shareEarnings Preview - TradingView
SeaStar Medical Holding Corp (ICU) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
SeaStar Medical Holding Corp expected to post a loss of 97 cents a shareEarnings Preview - TradingView
SeaStar Medical sets Aug. 12 webcast on results and progress - Stock Titan
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Yahoo Finance
Nuwellis (NASDAQ:NUWE) surges 130% as pediatric Aquadex update prompts heavy trading - TechStock²
SeaStar Medical Warrant (ICUCW) Flat at $0.02 as Trading Activity Remains MinimalRunaway Gap - dars.gov.et
SeaStar Medical Holding Corp - TradingKey
SeaStar Medical Holding Corp (ICU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Baird Jennifer A | Director |
Dec 19 '25 |
Buy |
0.24 |
4,200 |
987 |
36,200 |
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):